Procopio G - Search Results

1

Compassionate use of everolimus in a patient with a neuroendocrine tumor: a case report and discussion of the literature.

Pusceddu S, Milione M, Procopio G. Pusceddu S, et al. Among authors: procopio g. Oncol Res. 2011;19(8-9):403-6. doi: 10.3727/096504011x13123323849799. Oncol Res. 2011. PMID: 22329200 Review.

2

5-Fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors.

Bajetta E, Rimassa L, Carnaghi C, Seregni E, Ferrari L, Di Bartolomeo M, Regalia E, Cassata A, Procopio G, Mariani L. Bajetta E, et al. Among authors: procopio g. Cancer. 1998 Jul 15;83(2):372-8. doi: 10.1002/(sici)1097-0142(19980715)83:2<372::aid-cncr23>3.0.co;2-p. Cancer. 1998. PMID: 9669822 Clinical Trial.

3

Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours.

Bajetta E, Ferrari L, Procopio G, Catena L, Ferrario E, Martinetti A, Di Bartolomeo M, Buzzoni R, Celio L, Vitali M, Beretta E, Seregni E, Bombardieri E. Bajetta E, et al. Among authors: procopio g. Ann Oncol. 2002 Apr;13(4):614-21. doi: 10.1093/annonc/mdf064. Ann Oncol. 2002. PMID: 12056713 Free article. Clinical Trial.

4

Advances in diagnosis and therapy of neuroendocrine tumors.

Bajetta E, Procopio G, Buzzoni R, Catena L, Ferrari L, Del Vecchio M. Bajetta E, et al. Among authors: procopio g. Expert Rev Anticancer Ther. 2001 Oct;1(3):371-81. doi: 10.1586/14737140.1.3.371. Expert Rev Anticancer Ther. 2001. PMID: 12113104 Review.

5

Current treatments of neuroendocrine tumors role of biotherapy and chemotherapy.

Della Torre S, Procopio G, Fusi A, Catena L, Ferrari L, Nova P, Denaro A, Bichisao E, Bajetta E. Della Torre S, et al. Among authors: procopio g. Tumori. 2003 Mar-Apr;89(2):111-6. doi: 10.1177/030089160308900201. Tumori. 2003. PMID: 12841654 Review.

6

Update on the treatment of neuroendocrine tumors.

Bajetta E, Procopio G, Ferrari L, Catena L, Del Vecchio M, Bombardieri E. Bajetta E, et al. Among authors: procopio g. Expert Rev Anticancer Ther. 2003 Oct;3(5):631-42. doi: 10.1586/14737140.3.5.631. Expert Rev Anticancer Ther. 2003. PMID: 14599087 Review.

7

Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment?

Bajetta E, Catena L, Procopio G, Bichisao E, Ferrari L, Della Torre S, De Dosso S, Iacobelli S, Buzzoni R, Mariani L, Rosai J. Bajetta E, et al. Among authors: procopio g. Ann Oncol. 2005 Aug;16(8):1374-80. doi: 10.1093/annonc/mdi258. Epub 2005 Jun 6. Ann Oncol. 2005. PMID: 15939719 Free article.

8

Neuroendocrine tumors of the larynx: a clinical report and literature review.

Procopio G, Ricotta R, Fusi A, Celio L, De Dosso S, Catena L, Ferrari L, Quattrone P, Verzoni E, Bajetta E. Procopio G, et al. Tumori. 2006 Jan-Feb;92(1):72-5. Tumori. 2006. PMID: 16683387

9

Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?

Bajetta E, Catena L, Procopio G, De Dosso S, Bichisao E, Ferrari L, Martinetti A, Platania M, Verzoni E, Formisano B, Bajetta R. Bajetta E, et al. Among authors: procopio g. Cancer Chemother Pharmacol. 2007 Apr;59(5):637-42. doi: 10.1007/s00280-006-0306-6. Epub 2006 Aug 26. Cancer Chemother Pharmacol. 2007. PMID: 16937105

10

Pulmonary carcinoid tumours: indolent but not benign.

De Dosso S, Bajetta E, Procopio G, Cortinovis D, Buzzoni R, Catena L, Platania M, Verzoni E. De Dosso S, et al. Among authors: procopio g. Oncology. 2007;73(3-4):162-8. doi: 10.1159/000127382. Epub 2008 Apr 16. Oncology. 2007. PMID: 18418008

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

369 results

Search Page

Filters